effectively delivering gene-targeting drugs to the brain has remained an elusive goal. Against this backdrop, a research team from Tokyo University of Science (TUS), Japan, led by Professor Makiya ...

Getting therapeutic drugs past the blood-brain barrier has long been a major challenge in treating brain diseases. Now, researchers have explored how cholesterol-modified heteroduplex oligonucleotides ...

Conditional gene targeting based on excision or inversion of loxP-flanked DNA segments by Cre recombinase is a powerful technology for the analysis of gene function, but unexpected expression ...

The offspring carried the altered gene and passed it on. This breakthrough, known as gene targeting, has helped to develop new treatments for genetic diseases. Stem cells have the ability to ...

Scientists believe that activating these latent tooth buds using gene-targeting therapy could stimulate controlled regrowth ...

effectively delivering gene-targeting drugs to the brain has remained an elusive goal. Against this backdrop, a research team from Tokyo University of Science (TUS), Japan, led by Professor Makiya ...

$2,415 $2,300 $4,350 Gene targeting in mouse ES cells and chimera production – 129 ES cells $9,555 $9.085 $17,200 Gene targeting in mouse ES cells and chimera production – C57BL6 ES cells $9,765 ...

The FDA granted accelerated approval to the bispecific antibody zenocutuzumab (Bizengri) for NRG1 gene fusion-positive pancreatic adenocarcinoma and non-small cell lung cancer (NSCLC) on Wednesday.

Tenaya Therapeutics reports positive preclinical data for TN-201, a gene therapy for MYBPC3-associated hypertrophic cardiomyopathy, published in Nature Communications. Tenaya Therapeutics ...

today reported new data from its two preclinical programs targeting tau for the treatment of Alzheimer’s disease (AD). Data on tau silencing gene therapy VY1706 and anti-tau antibody VY7523 will ...